Form 4: Hims & Hers Health Executive Michael Chi Reports Stock Option Exercise and Sale
SEC Form 4 Filing
Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On November 5, 2024, Chi exercised stock options to acquire 2,054 shares of Class A Common Stock at a price of $11.53 per share.
- Simultaneously, Chi sold 2,054 shares of Class A Common Stock at $22 per share.
- These transactions were executed under a Rule 10b5-1 trading plan adopted on March 1, 2024.
- Following these transactions, Chi directly owns 193,980 shares of Class A Common Stock and 57,519 stock options.
- The stock options vest monthly over a 4-year period, starting on April 1, 2023, and expire on March 1, 2033.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment about the company's performance.
Future Outlook
The filing does not contain any forward-looking statements regarding the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. The use of a 10b5-1 trading plan is a common practice to avoid accusations of insider trading.
Comparison to Industry Standards
- Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
- Rule 10b5-1 trading plans are widely used by corporate insiders to schedule stock transactions in advance, providing a defense against potential insider trading allegations.
- The vesting schedule of the options (monthly over four years) is a typical arrangement to incentivize long-term commitment from the executive.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the use of a 10b5-1 plan suggests the impact is likely to be limited.
Key Dates
| Date | Description |
|---|---|
| 2023/04/01 | Options vesting start date. |
| 2024/03/01 | Date of adoption of Rule 10b5-1 trading plan. |
| 2024/11/05 | Date of stock option exercise and sale. |
| 2033/03/01 | Expiration date of stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.